The tech-heavy index has soared nearly 29% this year and is currently on pace for its best first half since 1983.
That year, the Nasdaq rallied 37.1% in the first half and finished 1983 up nearly 20%.
Their average price target implies about 34% upside compared with current levels.
Three-quarters of analysts covering the stock rate it a buy, and the average price target indicates 30% upside over the next 12 months.
Of the 14 analysts covering the stock, 71% rate it a buy, while the average analyst price target implies upside of nearly 64%.
Persons:
Ambrx, FANG, Canaccord Genuity
Organizations:
Nasdaq, Apple, Google, Nvidia, CNBC Pro, Diamondback Energy, Mobileye, Sarepta Therapeutics, U.S . Food, Drug Administration
Locations:
Texas, U.S